These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 37044200)

  • 41. Understanding the polymorphic behavior of sibenadet hydrochloride through detailed studies integrating structural and dynamical assessment.
    Cosgrove SD; Steele G; Austin TK; Plumb AP; Stensland B; Ferrari E; Roberts KJ
    J Pharm Sci; 2005 Nov; 94(11):2403-15. PubMed ID: 16200581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymorph screening of an active material.
    Láng P; Kiss V; Ambrus R; Farkas G; Szabó-Révész P; Aigner Z; Várkonyi E
    J Pharm Biomed Anal; 2013 Oct; 84():177-83. PubMed ID: 23845379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural characterization, physicochemical properties, and thermal stability of three crystal forms of nifedipine.
    Caira MR; Robbertse Y; Bergh JJ; Song M; De Villiers MM
    J Pharm Sci; 2003 Dec; 92(12):2519-33. PubMed ID: 14603498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and characterization of stoichiometric and nonstoichiometric hydrate forms of paroxetine HCl: reversible changes in crystal dimensions as a function of water absorption.
    Pina MF; Pinto JF; Sousa JJ; Fábián L; Zhao M; Craig DQ
    Mol Pharm; 2012 Dec; 9(12):3515-25. PubMed ID: 23051151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis, Characterization, and Crystal Chemistry of Tasimelteon, a Melatonin Agonist, in Its Anhydrous and Hemihydrate Forms.
    Ventimiglia G; Bellomi S; Barreca G; Giovannelli L; Masciocchi N
    J Pharm Sci; 2018 Feb; 107(2):543-549. PubMed ID: 28947337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crystal structure and physicochemical characterization of ambazone monohydrate, anhydrous, and acetate salt solvate.
    Muresan-Pop M; Braga D; Pop MM; Borodi G; Kacso I; Maini L
    J Pharm Sci; 2014 Nov; 103(11):3594-3601. PubMed ID: 25187325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of new crystalline forms of hydroxyprogesterone caproate.
    Caplette J; Frigo T; Jozwiakowski M; Shea H; Mirmehrabi M; Müller P
    Int J Pharm; 2017 Jul; 527(1-2):42-51. PubMed ID: 28522428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single crystal and powder diffraction characterization of three polymorphic forms of Acitretin.
    Malpezzi L; Magnone GA; Masciocchi N; Sironi A
    J Pharm Sci; 2005 May; 94(5):1067-78. PubMed ID: 15799018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dissolution properties, solid-state transformation and polymorphic crystallization: progesterone case study.
    Araya-Sibaja AM; Paulino AS; Rauber GS; Campos CE; Cardoso SG; Monti GA; Heredia V; Bianco I; Beltrano D; Cuffini SL
    Pharm Dev Technol; 2014 Nov; 19(7):779-88. PubMed ID: 24032356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of polymorphic ampicillin forms.
    Baraldi C; Tinti A; Ottani S; Gamberini MC
    J Pharm Biomed Anal; 2014 Nov; 100():329-340. PubMed ID: 25194347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study of retinoic acid polymorphism.
    Caviglioli G; Pani M; Gatti P; Parodi B; Cafaggi S; Bignardi G
    J Pharm Sci; 2006 Oct; 95(10):2207-21. PubMed ID: 16883553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Temperature dependent Raman and X-ray diffraction studies of anhydrous milk fat.
    Lambert A; Bougrioua F; Abbas O; Courty M; El Marssi M; Faivre V; Bresson S
    Food Chem; 2018 Nov; 267():187-195. PubMed ID: 29934155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physico-chemical characterisation of the modifications I and II of (R,S) propranolol hydrochloride: solubility and dissolution studies.
    Bartolomei M; Bertocchi P; Ramusino MC; Santucci N; Valvo L
    J Pharm Biomed Anal; 1999 Nov; 21(2):299-309. PubMed ID: 10703984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crystallization and transitions of sulfamerazine polymorphs.
    Zhang GG; Gu C; Zell MT; Burkhardt RT; Munson EJ; Grant DJ
    J Pharm Sci; 2002 Apr; 91(4):1089-100. PubMed ID: 11948548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Crystalline polymorphism of eflucimibe].
    Ribet JP; Pena R; Chauvet A; Patoiseau JF; Autin JM; Segonds R; Basquin M; Autret JM
    Ann Pharm Fr; 2002 May; 60(3):177-86. PubMed ID: 12050596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two new polymorphs and one dihydrate of lenalidomide: solid-state characterization study.
    Jia L; Li Z; Gong J
    Pharm Dev Technol; 2019 Nov; 24(9):1175-1180. PubMed ID: 31282833
    [No Abstract]   [Full Text] [Related]  

  • 57. Rapid conversion of API hydrates to anhydrous forms in aqueous media.
    Petrova RI; Peresypkin A; Mortko CJ; McKeown AE; Lee J; Williams JM
    J Pharm Sci; 2009 Nov; 98(11):4111-8. PubMed ID: 19384923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physicochemical characterization of the various solid forms of carbovir, an antiviral nucleoside.
    Nguyen NA; Ghosh S; Gatlin LA; Grant DJ
    J Pharm Sci; 1994 Aug; 83(8):1116-23. PubMed ID: 7983595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids.
    Tong HH; Shekunov BY; York P; Chow AH
    Pharm Res; 2001 Jun; 18(6):852-8. PubMed ID: 11474791
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploration of the physical states of riboflavin (free base) by mechanical milling.
    Henaff C; Siepmann J; Siepmann F; Danède F; Avettand-Fènoël MN; Vérin J; Fadel A; Willart JF
    Int J Pharm; 2023 Oct; 645():123416. PubMed ID: 37716485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.